Self-administered daily subcutaneous recombinant human erythropoietin: an open randomised dose-finding study in ESRD patients receiving peritoneal dialysis.
Slingeneyer
A
A
Service de Néphrologie, Hôpital Lapeyronie, CHU Montpellier, France.
Faller
B
B
Laroche
B
B
Ehmer
B
B
Mion
C
C
D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012646:Self Administration
D011994:Recombinant Proteins; D004921:Erythropoietin